Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2024 04:11 ET | Source: Research and Markets

India Diabetes Care Market Report 2024: Focus on Digital Health Solutions and Telemedicine, Personalized Medicine and Data Analytics

Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "India Diabetes Care Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
July 25, 2023 07:00 ET | Source: Research Nester

Model-based Enterprise Market revenue to reach USD 250 Billion by 2035, says Research Nester

New York, July 25, 2023 (GLOBE NEWSWIRE) -- The global model-based enterprise market size is projected to expand at ~24.17% CAGR between 2023 and 2035. The market is expected to garner a revenue of...
September 22, 2022 05:53 ET | Source: Research and Markets

Global Blood Glucose Test Strips Market Report 2022: Steady Shift of Blood Sugar Tests from Diagnostic Laboratories and Hospitals to Easy-To-Use Test Kits Driving Sector

Dublin, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The "Blood Glucose Test Strips Market By Distribution Type, By Diabetes Type, By End-use, and By Region Forecast to 2030" report has been added to ...
September 07, 2022 02:00 ET | Source: Zealand Pharma

Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon)

Company announcement – No. 38 / 2022 Agreement includes an upfront payment, development, regulatory, manufacturing and sales-based milestones of up to DKK 290 million to Zealand in addition to...
June 14, 2020 11:00 ET | Source: Zealand Pharma

Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association

Press release – No. 09 / 2020 Zealand Pharma presents clinical and non-clinical evidence for dasiglucagon rescue therapy at the 80th Scientific Sessions of the American Diabetes Association...
March 31, 2020 09:45 ET | Source: Zealand Pharma

Zealand Pharma submits New Drug Application to the U.S. Food and Drug Administration for the Dasiglucagon HypoPal® Rescue Pen for treatment of severe hypoglycemia

Press Release – No. 04 / 2020 Zealand Pharma submits New Drug Application to the U.S. Food and Drug Administration for the Dasiglucagon HypoPal® Rescue Pen for treatment of severe hypoglycemia The...
March 08, 2018 18:00 ET | Source: Xeris Pharmaceuticals, Inc.

Xeris Pharmaceuticals, Inc. Completes $55 million In New Financing To Support Ready-To-Use Glucagon Development

CHICAGO, IL, March 08, 2018 (GLOBE NEWSWIRE) -- CHICAGO, IL; March 8, 2018 (GLOBE NEWSWIRE) – Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel...
February 15, 2018 17:00 ET | Source: Xeris Pharmaceuticals, Inc.

Xeris Pharmaceuticals Achieves Phase 3 Milestones of its Ready-to-Use Glucagon Rescue Pen for the Treatment of Severe Hypoglycemia

Chicago, IL, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and...
February 08, 2018 18:30 ET | Source: Xeris Pharmaceuticals, Inc.

FDA Grants Orphan Drug Designation (ODD) for Xeris Pharmaceuticals' Ready-to-Use Glucagon for the Treatment of Hyperinsulinemic Hypoglycemia (HH). Results from Phase 2a Study in Post-Bariatric Hypoglycemia, Associated with HH, Published.

Chicago, IL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and...
November 09, 2016 09:00 ET | Source: XOMA Ltd.

XOMA Reports Third Quarter 2016 Achievements and Financial Results

BERKELEY, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced recent achievements and...

Next Page keyboard_arrow_right